Yan Feixiang, Wang Weiyue, Moossavi Maryam, Zhu Ping, Odell Noa, Xu Xiaolei
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA; Current address: Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center, USA.
J Mol Cell Cardiol. 2025 Jul 11;206:27-38. doi: 10.1016/j.yjmcc.2025.07.006.
Truncating TITIN variants (TTNtv) are the most prevalent genetic cause of dilated cardiomyopathy (DCM); however, key pathological signaling pathways remain elusive. We recently established a zebrafish model of TTNtv DCM and developed a F0-based genome editing technology for the rapid screening of genetic modifiers.
We screened multiple known cardiomyopathy signaling pathways through a F0-based genetic assay using a zebrafish ttntv DCM model. Because ERK signaling was identified from the screen, which was also independently identified as an altered signaling pathway during a cardiac transcriptomic study of the ttntv DCM model, we then assessed modifying effects of differentially expressed genes (DEGs) in ERK signaling.
erk1 and mek1 have been identified as therapeutic modifiers for ttntv DCM. Consistent with their modifying effects, we observed increased levels of phosphorylated Erk1 protein in ttntv adult zebrafish. Mechanistically, we showed that enhanced ERK signaling results in deregulated nutrient response, as indicated by the muted response of phosphorylated ribosomal protein S6 (pS6) expression in the heart during the fasting-refeeding cycle. The inhibition of ERK signaling is sufficient to rescue deregulated nutrient response and mitigate cardiac dysfunction. Further genetic screens of DEGs in ERK signaling identified ppp1r10, encoding a protein phosphatase 1 (PP1) regulatory subunit that regulates Mek1/Erk1 phosphorylation, as another therapeutic modifier gene that also rescues deregulated nutrient response.
An Erk - nutrient response signaling axis is disrupted in ttntv cardiomyopathy, which can be repaired by the inhibition of erk1, mek1 or ppp1r10, suggesting a new therapeutic avenue for TTNtv DCM.
截短型肌联蛋白变异体(TTNtv)是扩张型心肌病(DCM)最常见的遗传病因;然而,关键的病理信号通路仍不清楚。我们最近建立了TTNtv DCM的斑马鱼模型,并开发了一种基于F0的基因组编辑技术用于快速筛选遗传修饰因子。
我们使用斑马鱼ttntv DCM模型,通过基于F0的遗传检测筛选了多个已知的心肌病信号通路。由于在筛选中发现了ERK信号通路,并且在ttntv DCM模型的心脏转录组研究中也独立鉴定出该信号通路发生了改变,因此我们随后评估了ERK信号通路中差异表达基因(DEG)的修饰作用。
erk1和mek1已被确定为ttntv DCM的治疗性修饰因子。与它们的修饰作用一致,我们在ttntv成年斑马鱼中观察到磷酸化Erk1蛋白水平升高。从机制上讲,我们表明增强的ERK信号通路导致营养反应失调,这在禁食-再喂养周期中,心脏中磷酸化核糖体蛋白S6(pS6)表达的反应减弱中得到体现。抑制ERK信号通路足以挽救失调的营养反应并减轻心脏功能障碍。对ERK信号通路中DEG的进一步遗传筛选确定了ppp1r10,它编码一种调节Mek1/Erk1磷酸化的蛋白磷酸酶1(PP1)调节亚基,是另一个也能挽救失调营养反应的治疗性修饰基因。
在ttntv心肌病中,Erk - 营养反应信号轴被破坏,可通过抑制erk1、mek1或ppp1r10来修复,这为TTNtv DCM提示了一条新的治疗途径。